Mark A. Keibler
Alnylam Pharmaceuticals (United States)
ORCID: 0000-0002-5410-6543Also affiliated with Massachusetts Institute of Technology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “Differential substrate use in EGF‐ and oncogenic KRAS‐stimulated human mammary epithelial cells”.
Wentao Dong, Keegan Korthauer, Aaron M. Hosios, Sun Jin Moon, Lucas B. Sullivan +12 more
Mark A. Keibler, Sun Jin Moon, Patricia Cho, Nian Liu, Christian Berrios +7 more
Mark A. Keibler, Wentao Dong, Jenny Ghelfi, Thekla Cordes, Tamara Kanashova +8 more
Mark A. Keibler, Wentao Dong, Jenny Ghelfi, Thekla Cordes, Tamara Kanashova +8 more